Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sentí

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
BMJ (Clinical Research Ed.)|February 7, 2001
Why mortality from heart disease is low in France. High cholesterol may not have same effect on cardiovascular risk in southern Europe as elsewhereJ Marrugat, M Sentí
Revista Espanola De Cardiologia|September 1, 1994
[Lipoprotein(a) and the cardiovascular risk]J Pedro-Botet, M Sentí
Revista Clinica Espanola|August 1, 1994
[Peripheral vascular disease and risk factors]J Pedro-Botet, M Sentí
Metabolism: Clinical and Experimental|June 1, 2000
Differential effects of smoking on myocardial infarction risk according to the Gln/Arg 192 variants of the human paraoxonase geneM Sentí, C Aubó, M Tomás
Metabolism: Clinical and Experimental|September 29, 1998
The relationship between smoking and triglyceride-rich lipoproteins is modulated by genetic variation in the glycoprotein IIIa geneM Sentí, C Aubó, M Bosch
Medicina Clinica|September 15, 1990
[Hyperalphalipoproteinemia: study of a family]M Sentí, X Nogués, J Rubiés-Prat
Stroke|February 1, 1994
Apolipoprotein E polymorphism and ischemic cerebrovascular diseaseJ Pedro-Botet, M Sentí, J Rubiés-Prat
Atherosclerosis|May 30, 1998
A little more on lipoprotein profile in peripheral arterial diseaseJ Pedro-Botet, J Rubiés-Prat, M Sentí
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLsM Sentí, M Tomás, J Marrugat, et al.
Clinical Chemistry|August 1, 1991
Influence of intermediate-density lipoproteins on the accuracy of the Friedewald formulaM Sentí, J Pedro-Botet, X Nogués, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
BMJ (Clinical Research Ed.)|February 7, 2001
Why mortality from heart disease is low in France. High cholesterol may not have same effect on cardiovascular risk in southern Europe as elsewhereJ Marrugat, M Sentí
Revista Espanola De Cardiologia|September 1, 1994
[Lipoprotein(a) and the cardiovascular risk]J Pedro-Botet, M Sentí
Revista Clinica Espanola|August 1, 1994
[Peripheral vascular disease and risk factors]J Pedro-Botet, M Sentí
Metabolism: Clinical and Experimental|June 1, 2000
Differential effects of smoking on myocardial infarction risk according to the Gln/Arg 192 variants of the human paraoxonase geneM Sentí, C Aubó, M Tomás
Metabolism: Clinical and Experimental|September 29, 1998
The relationship between smoking and triglyceride-rich lipoproteins is modulated by genetic variation in the glycoprotein IIIa geneM Sentí, C Aubó, M Bosch
Medicina Clinica|September 15, 1990
[Hyperalphalipoproteinemia: study of a family]M Sentí, X Nogués, J Rubiés-Prat
Stroke|February 1, 1994
Apolipoprotein E polymorphism and ischemic cerebrovascular diseaseJ Pedro-Botet, M Sentí, J Rubiés-Prat
Atherosclerosis|May 30, 1998
A little more on lipoprotein profile in peripheral arterial diseaseJ Pedro-Botet, J Rubiés-Prat, M Sentí
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLsM Sentí, M Tomás, J Marrugat, et al.
Clinical Chemistry|August 1, 1991
Influence of intermediate-density lipoproteins on the accuracy of the Friedewald formulaM Sentí, J Pedro-Botet, X Nogués, et al.
Pageof 4